Cyclic Glycine-Proline
Also known as: cGP
Primary use: Cognitive enhancement and neuroprotection
What is Cyclic Glycine-Proline?
Cyclic glycine-proline (cGP) is a naturally occurring cyclic dipeptide derived from insulin-like growth factor-1 (IGF-1). It is found in plasma, breast milk, and cerebrospinal fluid and regulates IGF-1 bioavailability. Primarily used for its neuroprotective and cognitive enhancement properties, cGP is under research for applications in neurological conditions like Alzheimer's and Parkinson's disease. Though not FDA-approved, it shows promising safety and efficacy in preliminary studies.
- Enhances cognitive function
- Provides neuroprotection
- Supports cardiovascular health
cGP competes with IGF-1 for binding to IGFBP-3, regulating IGF-1 availability. It acts as an allosteric modulator of AMPA and GABA-A receptors and increases BDNF levels, leading to improved cognitive and neuroprotective effects.
Safety Tips
- 1DON'T exceed recommended doses of 20-50 μg daily.
- 2NEVER use if you have allergies to peptide components.
- 3AVOID inconsistent dosing times to maintain stability.
- 4DON'T mix with substances affecting IGF-1 without medical guidance.
- 5NEVER rely on unverified sources for purchase.
Who Should NOT Use
- Known allergy to peptides
Dosage & Protocols
Different purposes have different protocols, dosing, and considerations
Cognitive enhancement
moderate evidenceUsed to enhance memory retention, attention, and overall cognitive function. Studies show benefits in healthy aging and prevention of cognitive decline.
Evidence: Research includes multiple clinical observations and animal studies indicating increased BDNF and memory improvement.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
📋Community-Reported Protocols
The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| General cognitive support | 20-40 μg | 1x daily | Oral (capsule) |
| Neuroprotection/anti-aging | 40-50 μg | 1x daily | Oral (capsule) |
⏱️Pharmacokinetics
⚡Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
🧊Storage
Neuroprotection in neurological conditions
limited evidenceStudied for protecting neural cells and potentially reducing symptoms in Alzheimer's and Parkinson's disease.
Evidence: Limited human data but promising animal studies showing reduction in amyloid plaques and improved cognitive symptoms in neurodegenerative models.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
📋Community-Reported Protocols
The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Neuroprotection | 40-50 μg | 1x daily | Oral (capsule) |
⏱️Pharmacokinetics
⚡Reported Side Effects
This is not a complete list. Other side effects may occur.
🧊Storage
Harm Reduction Information
Quality Concerns
- Potential contamination from unregulated sources
- Mislabeling of cGP dose per serving
Safety Tips
- Start with the lowest effective dose to assess tolerance.
- Only purchase from reputable sources with third-party quality testing.
- Maintain consistent dosing schedule to ensure efficacy.
- Ensure proper storage to prevent degradation.
Warning Signs to Stop
- Unexpected allergic reactions
- Severe gastrointestinal discomfort
Seek Medical Help Immediately If
- Signs of severe allergic reactions like difficulty breathing
- Significant changes in mood or cognitive function
Frequently Asked Questions
How long until I see effects?
Cyclic Glycine-Proline typically shows cognitive benefits within 2-4 weeks of consistent use.
What time of day should I take it?
For cyclic glycine-proline, morning intake is preferred, with or without food.
How can I minimize side effects?
To minimize side effects, start with a low dose of cyclic glycine-proline and consult a healthcare provider if on IGF-1 affecting medication.
Does tolerance develop?
Generally, tolerance does not develop with cyclic glycine-proline due to its endogenous nature.
How should I store it?
Store cyclic glycine-proline supplements in a cool, dry place away from direct sunlight.
Do I need to cycle it?
Cyclic glycine-proline can be used continuously, but some users choose a 4-12 week cycle for evaluation.
Reported Combinations
Compounds reported to be used alongside Cyclic Glycine-Proline in community discussions. Not a recommendation.
IGF-1
Increases IGF-1 bioavailability and effectiveness.
BPC-157
Combines neuroprotective effects and supports IGF-1 activity.
Blackcurrant extract
Natural source of cGP, providing additional antioxidant effects.
Reported Interactions
Interactions reported in literature and community discussions.
Monitor for enhanced effects of IGF-1.
Monitor combination closely for unintended metabolic effects.
May require adjustment due to blood pressure-lowering effects of cGP.
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country. Information provided is for reference only and may change.
USA
not regulated
UK
not regulated
EU
not regulated
Australia
not regulated
Canada
not regulated
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Other Sources & Citations
Last updated: October 1, 2023
